Not finding it? Sign in to also search OpenAlex live.
-
A17 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY2021 Journal of the Canadian Association of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Laurent Peyrin‐Biroulet, Edward V. Loftus, Silvio Danese, Severine A.R.A. Vermeire, William J. Sandborn, Sandeep Nijhawan, +14 more
12citations -
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study2022 Journal of Gastrointestinal and Liver Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Rachel Louise West, Maurice G. Rüssel, Alexander G L Bodelier, Johan P. Kuijvenhoven, Karlien F. Bruin, Jeroen M. Jansen, +12 more
11citations -
Patient preferences in treatment options of ulcerative colitis: a discrete choice experiment2023 Scandinavian Journal of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Tessa Straatmijer, M. Elske van den Akker‐van Marle, Cyriel Y. Ponsioen, Danielle van der Horst, Menne PM. Scherpenzeel, Marjolijn Duijvestein, +1 more
11citations -
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study2024 United European Gastroenterology Journal article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Edouard J. Louis, Tadakazu Hisamatsu, Toshifumi Hibi∥, Louis Dron, +5 more
9citations -
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study2024 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Javier P. Gisbert, Stefan Schreiber, Corey Allan Siegel, Fernando Magro, Anna Jus, Chiara L. Whichello, +4 more
7citations -
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study2024 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 2 patents
Hiroshi Nakase, Silvio Danese, Walter Reinisch, Timothy E. Ritter, Yan Liang, Emily Wendt, +10 more
5citations -
Filgotinib induction-study baseline characteristics of patients with ulcerative colitis who achieve sustained corticosteroid-free remission: post hoc analysis of the phase 2b/3 SELECTION study2024 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Taku Kobayashi, Axel U Dignass, Xavier Roblin, Yoshie Takatori, Toshihiko Kaise, Alessandra Faria Oortwijn, +2 more
2citations -
Long-term clinical and endoscopic outcomes of ulcerative colitis after liver transplantation: a multicenter cohort study on the use and safety of advanced therapies2026 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ebru Ar, Irini Solomonidou, Henrike Lenzen, Miriam Wiestler, Claudia Veltkamp, Katharina Willuweit, +9 more
1citations -
Ecological resilience in ulcerative colitis: microbial dynamics of donor and resident species in a longitudinal fecal microbiota transplantation study2025 ISME Communications article Biochemistry, Genetics and Molecular Biology Gut microbiota and health Open access
Susanne Pinto, Elisa Benincà, Sam Nooij, Elisabeth M. Terveer, Josbert J. Keller, Andrea E. van der Meulen‐de Jong, +2 more
1citations -
Factors associated with response to filgotinib and the prognostic power of faecal calprotectin for ulcerative colitis in the phase 2b/3 SELECTION trial2025 Digestive and Liver Disease article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Edouard J. Louis, Stefan Schreiber, Tadakazu Hisamatsu, Toshifumi Hibi∥, Corinne Jamoul, Karine Muller, +4 more
0citations -
Shared CD4+ T cell receptor specificity groups in Crohn’s disease and ulcerative colitis2026 JCI Insight article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Joshua Elbridge Chan, Azam Mohsin, Jens Krijgsman, Ciska Lindelauf, Qinghui Mu, Brianna Cavalla, +4 more
0citations -
Ustekinuma b for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study2021 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Tessa Straatmijer, Vince B. C. Biemans, Frank Hoentjen, Nanne K.H. de Boer, Alexander G L Bodelier, Gerard D. H. Dijkstra, +14 more
43citations -
Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Kenji Watanabe, Laurent Peyrin‐Biroulet, Silvio Danese, Yasushi Fujitani, Margaux Faes, Alessandra Faria Oortwijn, +3 more
4citations -
Stromal Cell Subsets Show Model-Dependent Changes in Experimental Colitis and Affect Epithelial Tissue Repair and Immune Cell Activation2025 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Zhou Zhou, Jie Su, Bram W. van Os, Leonie G Plug, Eveline S. M. de Jonge‐Muller, Lei Brands, +4 more
2citations -
Prospective real-world experience with risankizumab in difficult-to-treat Crohn’s disease: results from the Dutch Initiative on Crohn and Colitis Registry2026 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Loriane Marina Michèle Verleye, Marieke J. Pierik, Annemarie Charlotte de Vries, Fiona D M van Schaik, Andrea E. van der Meulen‐de Jong, Willemijn Alexandra van Dop, +31 more
1citations -
Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment2021 Inflammatory Bowel Diseases article Medicine Colorectal Cancer Screening and Detection Open access
Anouk M. Wijnands, Maarten te Groen, Yonne Peters, Ad A. Kaptein, Bas Oldenburg, Frank Hoentjen, +1 more
5citations -
POSA350 Effect of Filgotinib on EQ-5D-5L and Work Productivity and Activity Impairment Among Patients with Ulcerative Colitis: Results from the Phase 2B/3 Selection Trial2022 Value in Health article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Silvio Danese, Brian G. Feagan, Stefan Schreiber, Ken Hasegawa, X. L.U., Alessandra Faria Oortwijn, +2 more
1citations -
The first identification of the epidemic Clostridioides difficile PCR ribotype 027 strain in Brazil: a case report of colitis in a patient from a public hospital in Rio de Janeiro2026 FEMS Microbiology Letters article Medicine Clostridium difficile and Clostridium perfringens research Open access
Andressa Azevedo, Otília Lupi, Patrícia Belford Rizz, Elizangela Paiva Pinheiro, A. C. Borges, Fabrício Moreira Cerri, +2 more
0citations -
Soluble mucosal addressin cell adhesion molecule 1 is a biomarker for pediatric ulcerative colitis2026 Molecular and Cellular Pediatrics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Moritz Muschaweck, Christian Gutbier, Gernot Sellge, Angeliki Pappa, Tobias G. Wenzl, Karim Hamesch, +2 more
0citations -
Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis2021 Mucosal Immunology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Maria E. Joosse, Fabienne Charbit‐Henrion, Remy Boisgard, Rolien C. Raatgeep, Dicky J. Lindenbergh-Kortleve, Lea M. M. Costes, +11 more
33citations